GUÍA MANEJO ANTIRRETROVIRAL PERSONAS VIH

18. European AIDS Clinical Society (EACS).Guidelines HIV Version
6, oct-2011.
19. ADA Guidelines. Standards of Medical Care in Diabetes–2012.
2012.
20. Inzucchi SE, et al. Management of Hyperglycemiain Type2
Diabetes: A Patient-Centered Approach. Diabetes Care. 2012; 35:
1364-1379.
21. Adapted from EACS guidelines Oct 2011. Management of
Hyperglycemiain Type2 Diabetes: A Patient-Centered Approach.
22. Matthews D.R. et al. Homeostasis model assessment: insulin
resistance and fl-cell function fromfasting plasma glucose and
insulin concentrations in man. Diabetologia 1985; 28 (7): 412-9.
23. Jonathan Levy et al. Correct Homeostasis Model Assessment
(HOMA) Evaluation Uses the Computer Program. Diabetes Care.
1998; 21: 2191-92.
Anexo II
1. CDC. Updated U.S. Public Health Service guidelines for the
management of occupational exposures to HIV and
recommendations for postexposure prophylaxis. MMWR. 2005;
54 (No. RR-9):1–52.
2. CDC. Antiretroviral postexposure prophylaxis after sexual,
injectiondrug use, or other nonoccupational exposure to HIV in
the United States: recommendations from the U.S. Department of
Health and Human Services. MMWR. 2005; 54(No. RR-2):1–20.
3. Bell DM. Occupational risk of human immunodeficiency virus
infection in health-care workers: an overview. Am J Med.
1997;102 (5B):9–15.
4. Richman KM, Rickman LS. The potential for transmission of
human immunodeficiency virus through human bites. J Acquir
Immune Defic Syndr. 1993;6:402
5. Vidmar L, Poljak M, Tomazic J, Seme K, Klavs I. Transmission of
HIV-1 by human bite. Lancet. 1996; 347:1762.
6. Pretty IA, Anderson GS, Sweet DJ. Human bites and the risk of
human immunodeficiency virus transmission. Am J Forensic Med
Pathol. 1999;20:232–9.
7. Wang SA, Panlilio AL, Doi PA, et al. Experience of health-care
workers taking postexposure prophylaxis after occupational
human immunodeficiency virus exposures: findings of the HIV
Postexposure Prophylaxis Registry. Infect Control Hosp
Epidemiol. 2000;21:780–5.
8. Swotinsky RB, Steger KA, Sulis C, Snyder S, Craven DE.
Occupational exposure to HIV: experience at a tertiary care
center. J Occup Environ Med. 1998;40:1102–9.
9. Parkin JM, Murphy M, Anderson J, El-Gadi S, Forster G, Pinching
AJ. Tolerability and side-effects of post-exposure prophylaxis for
HIV infection. Lancet. 2000;355:722–3.
10. Puro V. Post-exposure prophylaxis for HIV infection [Letter].
Lancet. 2000;355:1556–7.
11. Lee LM, Henderson DK. Tolerability of postexposure
antiretroviral prophylaxis for occupational exposures to HIV.
Drug Saf. 2001;24:587–97.
12. Russi M, Buitrago M, Goulet J, et al. Antiretroviral prophylaxis of
health care workers at two urban medical centers. J Occup Environ
Med. 2000;42:1092–100.
13. Garb JR. One-year study of occupational human
immunodeficiency virus postexposure prophylaxis. J Occup
Environ Med. 2002;44:265–70.
14. Grime PR, Risi L, Binns C, Carruthers JR, Williams S. Pan-
Thames survey of occupational exposure to HIV and the use of
post-exposure prophylaxis in 71 NHS trusts. J Infect.
2001;42:27–32.
15. Puro V, DeCarli G, Soldani F, et al. Adverse drug reactions
associated with PEP [Poster]. In: Program and Abstracts of the
10th Conference on Retroviruses and Opportunistic Infections,
Boston, Massachusetts, February 2003. Poster no. 711.
16. Gayet C., Magis C., et al. (2007b). Mujeres trabajadoras sexuales.
En: Prácticas sexuales de las poblaciones vulnerables a la epidemia
de VIH/SIDA en México. C. Gayet, C. Magis, D. Sacknoff, L. Guli
Eds. México, Flacso/SSA/CENSIDA/USAID. Pp: 129-143.
17. Secretaría de Salud. Programa Sectorial de Salud 2007-2012.
México; disponible en www.salud.gob.mx
18. Norma Oficial Mexicana NOM-010-SSA2-2010, Para la
prevención y control de la infección por Virus de la
Inmunodeficiencia Humana. Diario Oficial de la Federación, 15
de octubre de 2010.
19. Modificación a la Norma Oficial Mexicana NOM-190-SSA1-
1999, Prestación de servicios de salud. Criterios para la atención
médica de la violencia familiar, para quedar como NOM-046-
SSA2-2005, Violencia familiar, sexual y contra las mujeres.
Criterios para la prevención y atención.Diario Oficial de la
Federación, 16 de abril de 2009.
20. Australian National guidelines for post exposure prophylaxis after
occupational and non-occupational exposure to HIV, Approved
March 2007 Online ISBN: 1 74186 125 X Publications Approval
Number: 3939.Disponible en http://www.ashm.org.au/pepguidelines/PEP_GUIDELINES_FINAL_18FEB13.pdf
21. Secretaria de Salud. Manual de Atención a Personas Violadas.
México 2004.
22. Sexually Transmitted Diseases Treatment Guidelines, 2006.
Centers for Disease Control and Prevention. Morbidity &
Mortality Weekly Report, December 17, 2010 / Vol. 59 / No.
RR-12
23. Linden, Judith A. Care of Adult Patient after Sexual Assault. N
Engl J Med. 2011, 1: 834 – 841.
24. Secretaria de Salud. Guía de prevención, diagnóstico y tratamiento
de las Infecciones de Transmisión Sexual. CENSIDA. México
2009.
25. 128. Ford N, Irvine C, Shubber Z, et al. Adherence to HIV
postexposure prophylaxis: a systematic review and metaanalysis.
AIDS. 2014;28(18):2721-2727.
26. Kim JC, Askew I, Muvhango L, et al. Comprehensive care and
HIV prophylaxis after sexual assault in rural South Africa: the
Refentse Intervention Study. BMJ. 2009;338:b515.
27. Loutfy MR, Macdonald S, Myhr T, et al. Prospective cohort study
of HIV post-exposure prophylaxis for sexual assault survivors.
Antivir Ther. 2008;13(1):87-95.
28. The California Task Force on Non-Occupational PEP, the
California Department of Health Services, Office of AIDS.
Offering HIV Post-Exposure Prophylaxis (PEP) Following Non-
Occupational Exposures Recommendations for Health Care
Providers in the State of California Sacramento, California,2004:
Disponible
en:
www.cdph.ca.gov/programs/aids/Documents/RPT2004Offerin
gPEPFollowingNonOccupExp2004-06.pdf.
29. CDC. Updated Guidelines for Antiretroviral Postexposure
Prophylaxis After Sexual, Injection Drug Use, or Other
Nonoccupational Exposure to HIV— United States, 2016.
Disponible en: www.cdc.gov/hiv/pdf/programresources/cdchiv-npep-guidelines.pdf
30. Foster C, Tudor-Williams G, Bamford A. Post-Exposure
Prophylaxis (PEP) Guidelines for children and
adolescentspotentially exposed to blood-borne viruses. CHIVA
Childrens HIV Association Guidelines, June
2015.http://www.chiva.org.uk/files/2814/3575/6995/CHIV
A_PEP_2015_final.pdf
31. Grupo de expertos de la Secretaría del Plan Nacional sobre el Sida
(SPNS), Grupo de Estudio de Sida (GeSIDA) y col. Documento de
Consenso sobre profilaxis postexposición ocupacionaly no
ocupacional en relación con el VIH, VHB y VHC en adultos y
niños. Enferm Infecc Microbiol Clin. 2016;34(2):121.e1–
121.e15.
32. Updated Guidelines for Antiretroviral Postexposure Prophylaxis
After Sexual Injection Drug Use or Other Non occupational
Exposure to HIV—United States 2016. DHHS
33. Upton D Allen, Noni E MacDonald. Paediatr Child Health
2014;19(8):429-33
34. Physical and Sexual Abuse In Children, Emergency Department
Management , Clinical Practice Guideline, 10/15, Cardinal
Glennon Children Hospital
35. Alberta Guidelines for Non-Occupational, Occupational and
Mandatory Testing and Disclosure Act
36. Post-Exposure Management and Prophylaxis: HIV, Hepatitis B,
Hepatitis C and Sexually Transmitted Infections, feb 2015
37. Sexually Transmitted Diseases Treatment Guidelines, 2015,
MMWR June 5, 2015
38. Corina Araceli García-Piña, Arturo Loredo-Abdalá , Jorge Trejo
Hernández ***, Dra. Abigail Casas Muñoz. Violación sexual en
niños y adolescentes: una urgencia médica
39. Acta Pediátrica de México Volumen 34, Núm. 5, septiembreoctubre,
2013:288-294
40. Guías para el tratamiento de las infecciones de transmisión
sexual. Organización Mundial de la Salud, 2015
Anexo III
1. Boulware DR, M.D., M.P.H., et al. Timing of antiretroviral
therapy after diagnosis of cryptococcal meningitis. N Engl J Med.
Jun 2014;370:2487-98.
2. Jabs DA, Ahuja A, Van Natta M, et al. Course of cytomegalovirus
retinitis in the era of highly active antiretroviral therapy: five-year
180